On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Exvastat Ltd's own share of each project, not the project's full budget.
- Horizon 2020€1.8M · 2 projects
Projects
2 EU-funded projects, newest first. Exvastat Ltd led 2 of them as coordinator. Each links to the official record.
- ImpentriCoordinator
First effective pharmacotherapy for ARDS to lower mortality and improve quality of life of patients.
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€1.3Mtheir share - ImpentriCoordinator
Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€537ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
Fields it works in
Research fields recorded on its Horizon projects.
- coronaviruses
- immunology
- mortality
- pathology
- pharmaceutical drugs
- pharmacokinetics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.